Raymond James & Associates’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-13,435
Closed -$632K 3925
2023
Q2
$632K Buy
13,435
+3,719
+38% +$185K ﹤0.01% 2780
2023
Q1
$408K Buy
9,716
+3,411
+54% +$147K ﹤0.01% 3036
2022
Q4
$240K Buy
+6,305
New +$241K ﹤0.01% 3340
2021
Q2
Sell
-9,702
Closed -$726K 4188
2021
Q1
$726K Sell
9,702
-3,058
-24% -$251K ﹤0.01% 2728
2020
Q4
$1.1M Sell
12,760
-83,725
-87% -$6.17M ﹤0.01% 2278
2020
Q3
$5.9M Buy
96,485
+69,147
+253% +$3.5M 0.01% 1134
2020
Q2
$1.14M Buy
27,338
+6,397
+31% +$232K ﹤0.01% 2073
2020
Q1
$601K Buy
20,941
+12,331
+143% +$714K ﹤0.01% 2298
2019
Q4
$622K Sell
8,610
-26,648
-76% -$3.28M ﹤0.01% 2571
2019
Q3
$4.95M Sell
35,258
-2,133
-6% -$357K 0.01% 1231
2019
Q2
$6.85M Buy
37,391
+4,284
+13% +$731K 0.01% 1062
2019
Q1
$5.27M Buy
33,107
+10,602
+47% +$1.54M 0.01% 1159
2018
Q4
$2.16M Buy
22,505
+631
+3% +$72.2K ﹤0.01% 1606
2018
Q3
$3.09M Buy
21,874
+3,341
+18% +$516K ﹤0.01% 1533
2018
Q2
$2.9M Buy
18,533
+4,304
+30% +$676K ﹤0.01% 1535
2018
Q1
$2.29M Sell
14,229
-352
-2% -$59.8K ﹤0.01% 1620
2017
Q4
$2.4M Buy
14,581
+414
+3% +$40.1K ﹤0.01% 1575
2017
Q3
$883K Sell
14,167
-8,631
-38% -$678K ﹤0.01% 2174
2017
Q2
$1.82M Buy
22,798
+8,561
+60% +$619K ﹤0.01% 1629
2017
Q1
$1.01M Sell
14,237
-10,218
-42% -$599K ﹤0.01% 1973
2016
Q4
$1.25M Buy
24,455
+17,051
+230% +$804K ﹤0.01% 1806
2016
Q3
$341K Buy
+7,404
New +$301K ﹤0.01% 2537

Other funds holding SAGE